这是一篇来自已证抗体库的有关人类 金属蛋白酶组织抑制剂-1 (TIMP-1) 的综述,是根据26篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合金属蛋白酶组织抑制剂-1 抗体。
金属蛋白酶组织抑制剂-1 同义词: CLGI; EPA; EPO; HCI; TIMP; TIMP-1

赛默飞世尔
小鼠 单克隆(F31 P2 A5)
  • 免疫印迹; 小鼠; 图 4b
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo Fisher Scientific, MA1-773)被用于被用于免疫印迹在小鼠样本上 (图 4b). Molecules (2019) ncbi
小鼠 单克隆(102D1)
  • 其他; 人类; 图 s1
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo Fisher, MS-608-p0)被用于被用于其他在人类样本上 (图 s1). Cell Chem Biol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:2000; 图 s5a
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo fisher, PA5-13668)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 s5a). Arterioscler Thromb Vasc Biol (2017) ncbi
小鼠 单克隆(F31 P2 A5)
  • 免疫印迹; 小鼠; 图 3
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo Fisher Scientific, MA1-773)被用于被用于免疫印迹在小鼠样本上 (图 3). J Orthop Res (2017) ncbi
小鼠 单克隆(F31 P2 A5)
  • 免疫印迹; 小鼠; 1:500; 图 6
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo Scientific, MA1-773)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6). Inflammation (2017) ncbi
小鼠 单克隆(102D1)
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo, MA5-13688)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Clin Breast Cancer (2016) ncbi
小鼠 单克隆(102D1)
  • 免疫组化; 人类
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Labvision, MS-608-PCL)被用于被用于免疫组化在人类样本上. Appl Immunohistochem Mol Morphol (2016) ncbi
小鼠 单克隆(102D1)
  • 免疫组化; 人类; 1:25
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Thermo Fisher Scientific, 102D1)被用于被用于免疫组化在人类样本上浓度为1:25. BMC Cancer (2014) ncbi
小鼠 单克隆(102D1)
  • 免疫组化-石蜡切片; 人类; 1:600
赛默飞世尔金属蛋白酶组织抑制剂-1抗体(Neo Markers, 102D1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:600. Ann Vasc Surg (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(2A5)
  • 免疫组化-石蜡切片; 小鼠; 图 6a
圣克鲁斯生物技术金属蛋白酶组织抑制剂-1抗体(Santa Cruz, sc-21734)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6a). Cardiovasc Diabetol (2018) ncbi
小鼠 单克隆(2A5)
  • 免疫印迹; 大鼠; 1:500; 图 8
圣克鲁斯生物技术金属蛋白酶组织抑制剂-1抗体(Santa Cruz, SC21734)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 8). Int J Mol Med (2015) ncbi
小鼠 单克隆(G-6)
  • 免疫印迹; 人类
圣克鲁斯生物技术金属蛋白酶组织抑制剂-1抗体(Santa Cruz Biotechnology, sc-365905)被用于被用于免疫印迹在人类样本上. J Leukoc Biol (2014) ncbi
小鼠 单克隆(G-6)
  • 免疫印迹; 人类
圣克鲁斯生物技术金属蛋白酶组织抑制剂-1抗体(Santa Cruz Biotechnology, sc-365905)被用于被用于免疫印迹在人类样本上. Mol Med Rep (2014) ncbi
小鼠 单克隆(2A5)
  • 免疫印迹; domestic rabbit; 1:2000
圣克鲁斯生物技术金属蛋白酶组织抑制剂-1抗体(Santa Cruz Biotechnology, sc-21734)被用于被用于免疫印迹在domestic rabbit样本上浓度为1:2000. Exp Ther Med (2014) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:5000; 图 5e
艾博抗(上海)贸易有限公司金属蛋白酶组织抑制剂-1抗体(Abcam, ab38978)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 5e). Aging (Albany NY) (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 2b
艾博抗(上海)贸易有限公司金属蛋白酶组织抑制剂-1抗体(Abcam, ab61224)被用于被用于免疫印迹在大鼠样本上 (图 2b). J Neurosci (2018) ncbi
domestic goat 多克隆
  • 免疫印迹; domestic rabbit; 0.2 ug/ml; 图 6b
艾博抗(上海)贸易有限公司金属蛋白酶组织抑制剂-1抗体(Abcam, ab126847)被用于被用于免疫印迹在domestic rabbit样本上浓度为0.2 ug/ml (图 6b). Int J Mol Med (2017) ncbi
domestic rabbit 单克隆(EPR1550)
  • 免疫印迹; 人类; 图 3c
艾博抗(上海)贸易有限公司金属蛋白酶组织抑制剂-1抗体(Abcam, ab109125)被用于被用于免疫印迹在人类样本上 (图 3c). Sci Rep (2016) ncbi
domestic rabbit 单克隆(EPR1550)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1c, 1g
艾博抗(上海)贸易有限公司金属蛋白酶组织抑制剂-1抗体(Abcam, ab109125)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1c, 1g). Onco Targets Ther (2016) ncbi
西格玛奥德里奇
小鼠 单克隆(4D12)
  • 免疫印迹; 人类; 图 6b, 6d, 6h
西格玛奥德里奇金属蛋白酶组织抑制剂-1抗体(Sigma-Aldrich, WH0007076M1)被用于被用于免疫印迹在人类样本上 (图 6b, 6d, 6h). Aging (Albany NY) (2019) ncbi
安迪生物R&D
domestic goat 多克隆
  • 免疫印迹; 人类; 图 1d
安迪生物R&D金属蛋白酶组织抑制剂-1抗体(R&D Systems, AF970)被用于被用于免疫印迹在人类样本上 (图 1d). Cell Rep (2019) ncbi
小鼠 单克隆(150911)
  • 免疫印迹; 大鼠; 1:500; 图 5
安迪生物R&D金属蛋白酶组织抑制剂-1抗体(R&D System, MAB580)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5). Sci Rep (2016) ncbi
domestic goat 多克隆
  • 免疫印迹; 人类; 1:600; 图 4
安迪生物R&D金属蛋白酶组织抑制剂-1抗体(R&D Systems, AF 970)被用于被用于免疫印迹在人类样本上浓度为1:600 (图 4). Med Sci Sports Exerc (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D10E6)
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司金属蛋白酶组织抑制剂-1抗体(cell signalling, 8946)被用于被用于免疫印迹在人类样本上 (图 7a). Int J Mol Sci (2016) ncbi
domestic rabbit 单克隆(D10E6)
  • 免疫印迹; 人类; 1:1000; 图 6
赛信通(上海)生物试剂有限公司金属蛋白酶组织抑制剂-1抗体(Cell Signaling, 8946)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). BMC Cancer (2015) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(VT7)
  • 免疫组化; 人类; 1:50; 图 1
丹科医疗器械技术服务(上海)有限公司金属蛋白酶组织抑制剂-1抗体(Dako, VT7)被用于被用于免疫组化在人类样本上浓度为1:50 (图 1). J Oral Pathol Med (2015) ncbi
文章列表
  1. Yang Y, Tang F, Wei F, Yang L, Kuang C, Zhang H, et al. Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice. Aging (Albany NY). 2019;11:10016-10030 pubmed 出版商
  2. Yang L, Jiang Q, Li D, Zhou X, Yu D, Zhong J. TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer. Aging (Albany NY). 2019;11:8998-9012 pubmed 出版商
  3. Wiley C, Liu S, Limbad C, Zawadzka A, Beck J, Demaria M, et al. SILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells. Cell Rep. 2019;28:3329-3337.e5 pubmed 出版商
  4. Yi R, Zhang J, Sun P, Qian Y, Zhao X. Protective Effects of Kuding Tea (Ilex kudingcha C. J. Tseng) Polyphenols on UVB-Induced Skin Aging in SKH1 Hairless Mice. Molecules. 2019;24: pubmed 出版商
  5. Nasiri Ansari Ν, Dimitriadis G, Agrogiannis G, Perrea D, Kostakis I, Kaltsas G, et al. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice. Cardiovasc Diabetol. 2018;17:106 pubmed 出版商
  6. Rempe R, Hartz A, Soldner E, Sokola B, Alluri S, Abner E, et al. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy. J Neurosci. 2018;38:4301-4315 pubmed 出版商
  7. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  8. Riascos Bernal D, Chinnasamy P, Gross J, Almonte V, Egaña Gorroño L, Parikh D, et al. Inhibition of Smooth Muscle ?-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37:879-888 pubmed 出版商
  9. Liu J, Hu F, Tang J, Tang S, Xia K, Wu S, et al. Homemade-device-induced negative pressure promotes wound healing more efficiently than VSD-induced positive pressure by regulating inflammation, proliferation and remodeling. Int J Mol Med. 2017;39:879-888 pubmed 出版商
  10. Wagner J, Jaurich H, Wallner C, Abraham S, Becerikli M, Dadras M, et al. Diminished bone regeneration after debridement of posttraumatic osteomyelitis is accompanied by altered cytokine levels, elevated B cell activity, and increased osteoclast activity. J Orthop Res. 2017;35:2425-2434 pubmed 出版商
  11. Chauhan P, Dash D, Singh R. Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma. Inflammation. 2017;40:248-258 pubmed 出版商
  12. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed 出版商
  13. Lu X, Duan L, Xie H, Lu X, Lu D, Lu D, et al. Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction. Onco Targets Ther. 2016;9:4343-9 pubmed 出版商
  14. Magnowska M, Gorkiewicz T, Suska A, Wawrzyniak M, Rutkowska Wlodarczyk I, Kaczmarek L, et al. Transient ECM protease activity promotes synaptic plasticity. Sci Rep. 2016;6:27757 pubmed 出版商
  15. Cid S, Eiró N, Gonzalez L, Béridze N, Vazquez J, Vizoso F. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas. Clin Breast Cancer. 2016;16:e83-91 pubmed 出版商
  16. Wang X, Wang N, Li H, Liu M, Cao F, Yu X, et al. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine. Int J Mol Sci. 2016;17:577 pubmed 出版商
  17. Nyberg M, Fiorenza M, Lund A, Christensen M, Rømer T, Piil P, et al. Adaptations to Speed Endurance Training in Highly Trained Soccer Players. Med Sci Sports Exerc. 2016;48:1355-64 pubmed 出版商
  18. Yan G, Wang Q, Hu S, Wang D, Qiao Y, Ma G, et al. Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury. Int J Mol Med. 2015;36:1001-11 pubmed 出版商
  19. Fullár A, Dudás J, Oláh L, Hollósi P, Papp Z, Sobel G, et al. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer. 2015;15:256 pubmed 出版商
  20. El Rebey H, Aiad H, Abulkheir I, Asaad N, El Wahed M, Abulkasem F, et al. The Predictive and Prognostic Role of Topoisomerase IIα and Tissue Inhibitor of Metalloproteinases 1 Expression in Locally Advanced Breast Carcinoma of Egyptian Patients Treated With Anthracycline-based Neoadjuvant Chemotherapy. Appl Immunohistochem Mol Morphol. 2016;24:167-78 pubmed 出版商
  21. Kim G, Lee J, Choi Y, Lee K, Lee J, Nam J, et al. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer. BMC Cancer. 2014;14:959 pubmed 出版商
  22. Bodnar M, Szylberg Ł, Kazmierczak W, Marszalek A. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors. J Oral Pathol Med. 2015;44:437-43 pubmed 出版商
  23. Bailon E, Ugarte Berzal E, Amigo Jiménez I, Van den Steen P, Opdenakker G, Garcia Marco J, et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. J Leukoc Biol. 2014;96:185-99 pubmed 出版商
  24. Jiang J, Liu Y, Fang W, Liu F. Sperm?associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin. Mol Med Rep. 2014;10:417-22 pubmed 出版商
  25. Wang L, Wang J, Wang Y, Fu Q, Lei Y, Nie Z, et al. Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure. Exp Ther Med. 2014;7:329-334 pubmed
  26. Roggério A, Sambiase N, Palomino S, de Castro M, da Silva E, Stolf N, et al. Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis. Ann Vasc Surg. 2013;27:964-71 pubmed 出版商